Aarti Pharmalabs Limited (NSE:AARTIPHARM)

India · Delayed Price · Currency is INR

796.00

+30.55 (3.99%)

May 12, 2025, 3:30 PM IST

Revenue by Product

Fiscal year is April - March.

Fiscal Year	FY 2023	FY 2022
Period Ending	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Pharmaceutical	18.53B	Log In
Pharmaceutical Growth	-4.76%	Log In

Revenue by Geography

Fiscal year is April - March.

Fiscal Year	FY 2023	FY 2022
Period Ending	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
India	9.74B	Log In
India Growth	-49.91%	Log In
International	8.44B	Log In
Global	345.14M	Log In